Correlation Between Molecular Templates and Abeona Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and Abeona Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and Abeona Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and Abeona Therapeutics, you can compare the effects of market volatilities on Molecular Templates and Abeona Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of Abeona Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and Abeona Therapeutics.
Diversification Opportunities for Molecular Templates and Abeona Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Abeona is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and Abeona Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abeona Therapeutics and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with Abeona Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abeona Therapeutics has no effect on the direction of Molecular Templates i.e., Molecular Templates and Abeona Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Templates and Abeona Therapeutics
Given the investment horizon of 90 days Molecular Templates is expected to generate 8.65 times more return on investment than Abeona Therapeutics. However, Molecular Templates is 8.65 times more volatile than Abeona Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Abeona Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 45.00 in Molecular Templates on September 1, 2024 and sell it today you would lose (8.00) from holding Molecular Templates or give up 17.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Molecular Templates vs. Abeona Therapeutics
Performance |
| Timeline |
| Molecular Templates |
| Abeona Therapeutics |
Molecular Templates and Abeona Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and Abeona Therapeutics
The main advantage of trading using opposite Molecular Templates and Abeona Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, Abeona Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will offset losses from the drop in Abeona Therapeutics' long position.| Molecular Templates vs. Century Therapeutics | Molecular Templates vs. Kezar Life Sciences | Molecular Templates vs. Mineralys Therapeutics, Common | Molecular Templates vs. Nkarta Inc |
| Abeona Therapeutics vs. Tff Pharmaceuticals | Abeona Therapeutics vs. Eliem Therapeutics | Abeona Therapeutics vs. Inhibrx | Abeona Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |